₩ 132000
Key Takeaways
Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
LigaChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. It offers medical equipment and therapeutic products such as antibiotics, anti-coagulants, oncology, antibody-drug conjugate, and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of 141080.KQ is 173437 and suggests 18% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
